Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
Clinical trial NCT04720768 · UNKNOWN
Trial details
- NCT number
- NCT04720768
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2024-12-04
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.